Carrie Shawber is a prominent inventor based in the Township of Washington, NJ (US). She has made significant contributions to the field of medical treatments, particularly in addressing vascular malformations. With a total of 7 patents to her name, her work has the potential to impact many lives.

Latest Patents

Among her latest patents, Shawber has developed compositions and methods for the treatment and prevention of vascular malformations. These methods include the administration of proteasome inhibitors, omipalisib, disulfiram, and agents targeting specific genes in the PI3K/AKT/mTOR or RAS/RAF/MAPK pathways. Additionally, she has created human Notch1 decoys, which are fusion proteins designed to treat age-related macular degeneration, diabetic retinopathy, and cancer.

Career Highlights

Carrie Shawber is affiliated with Columbia University, where she continues her research and development in innovative medical solutions. Her work is characterized by a commitment to advancing healthcare through scientific discovery and application.

Collaborations

Shawber has collaborated with notable colleagues, including Jan K Kitajewski and Yasuhiro Funahashi, enhancing the scope and impact of her research.

Conclusion

Carrie Shawber's innovative contributions to the treatment of vascular malformations and related conditions highlight her role as a leading inventor in the medical field. Her ongoing work promises to bring new hope to patients facing these challenges.

This text is generated by artificial intelligence and may not be accurate.